Exome Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.71M | Buy |
+98,600
| New | +$1.71M | 1.27% | 31 |
|
|
2025
Q1 | – | Sell |
-119,467
| Closed | -$3.81M | – | 54 |
|
|
2024
Q4 | $3.81M | Buy |
119,467
+19,100
| +19% | +$609K | 2.86% | 12 |
|
|
2024
Q3 | $2.89M | Buy |
100,367
+53,467
| +114% | +$1.54M | 1.96% | 22 |
|
|
2024
Q2 | $1.8M | Buy |
+46,900
| New | +$1.8M | 1.6% | 30 |
|
|
2024
Q1 | – | Sell |
-7,249
| Closed | -$434K | – | 54 |
|
|
2023
Q4 | $434K | Buy |
+7,249
| New | +$434K | 0.43% | 48 |
|